Dr. Jeremy Shefner and Dr. Jonathan Katz will present the DPS in ALS clinical trial and discuss why the completion of this particular study is so important for the PALS population. They will review the study rationale and background of the DPS device, provide an overview of the inclusion criteria and talk about what would be expected of a patient if they were to participate in the study.
Presented on August 6, 2014.
